Fachbeiträge

 

 

Der VFTH e.V. präsentiert Forschungsergebnisse gewonnen aus Daten erfasst mit smart medication

 

 

"Comparison of electronic documentation with smart medication between 2014 and 2017

 

W. Mondorf, H. Eichler, R. Fischer, K. Holstein, R. Klamroth, A. Nimtz-Talaska, H. Richter, K. Severin, C. Wermes, VFTH e.V.

 

63th Annual Meeting of the Society of Thrombosis and Haemostasis Research, 27. Feb. - 02. Mrz. 2019, Berlin/Germany

 

Poster Nummer: P03-1

Comparison of electronic documentation with smart medication™ between 2014 and 2017
Annual joint bleeding rate (AJBR) and annual factor VIII/IX consumption (AFC) differ widely among patients with severe haemophilia. The year to year pattern may, however, be similar.
GTH2019_Poster1.pdf
Adobe Acrobat Dokument 1.6 MB

 

"smart medication ITP – feasibility of online surveillance in patients with immunthrombocytopenia

 

W. Mondorf, B. Schmoldt, A. Rösch

 

63th Annual Meeting of the Society of Thrombosis and Haemostasis Research, 27. Feb. - 02. Mrz. 2019, Berlin/Germany

 

Poster Nummer: P01-7

 

Smart medication™ ITP – feasibility of online surveillance in patients with immunthrombocytopenia
smart medicationTM was successfully implemented in haemophilia home treatment. The aim of this investigation was to analyse the feasability of a modified APP and internet platform for surveillance of patients with immunthrombocytopenia (ITP).
GTH2019_Poster2.pdf
Adobe Acrobat Dokument 2.4 MB

  

"Impact of GDPR (DSGVO) on smart medication electronic patient diary

 

A. Rösch, D. Schmoldt, W. Mondorf, R. Fischer

 

63th Annual Meeting of the Society of Thrombosis and Haemostasis Research, 27. Feb. - 02. Mrz. 2019, Berlin/Germany

 

Poster Nummer: P09-10

Impact of GDPR (DSGVO) on smart medication™ electronic patient diary
May, 25th 2018 the GDPR (english: General Data Protection Regulation, German DSGVO: Datenschutz-Grundverordnung) was coming into effect throughout the European Community. It is shown how the new regulation impacts the smart medication™ platform in respect of data processing of personal health information.
Poster DSGVO_A4.pdf
Adobe Acrobat Dokument 1.4 MB

 

"smart medication - a pilot study for investigating the feasibility of speech recognition of natural language to access electronic patient diary

 

A. Rösch, D. Schmoldt, W. Mondorf, R. Fischer

 

63th Annual Meeting of the Society of Thrombosis and Haemostasis Research, 27. Feb. - 02. Mrz. 2019, Berlin/Germany

 

Poster Nummer: P09-9 

smart medicationTM – a pilot study for investigating the feasibility of speech recognition of natural language to access electronic patient diary
smart medicationTM was successfully implemented in haemophilia home treatment. Until now patients enter treatment data using either a smartphone-app or a web-browser. The aim of this study was to analyse and evaluate the use of speech recognition as an additional interface to the electronic diary.
2019_SpeechRecognitionA4.pdf
Adobe Acrobat Dokument 1.1 MB
smart medicationTM – a pilot study for investigating the feasibility of speech recognition of natural language to access electronic patient diary
smart medicationTM was successfully implemented in haemophilia home treatment. Until now patients enter treatment data using either a smartphone-app or a web-browser. The aim of this study was to analyse and evaluate the use of speech recognition as an additional interface to the electronic diary.
2019_SpeechRecognitionA4V2.pdf
Adobe Acrobat Dokument 1.1 MB